XML 114 R78.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Segments and Geographic Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended
--- | --- | ---
May 31, 2018 | Feb. 28, 2018 | Nov. 30, 2017 | Aug. 31, 2017 | May 31, 2017 | Feb. 28, 2017 | Nov. 30, 2016 | Aug. 31, 2016 | May 31, 2018 | May 31, 2017 | May 31, 2016
Net sales by Product Category |  |  |  |  |  |  |  |  |  |  |
Net sales | $ 88,317 | $ 83,851 | $ 86,706 | $ 85,411 | $ 86,914 | $ 85,602 | $ 89,029 | $ 88,098 | $ 344,285 | $ 349,643 | $ 353,890
Peripheral Vascular |  |  |  |  |  |  |  |  |  |  |
Net sales by Product Category |  |  |  |  |  |  |  |  |  |  |
Net sales |  |  |  |  |  |  |  |  | 202,334 | 208,602 | 205,620
Vascular Access |  |  |  |  |  |  |  |  |  |  |
Net sales by Product Category |  |  |  |  |  |  |  |  |  |  |
Net sales |  |  |  |  |  |  |  |  | 92,760 | 96,481 | 99,375
Oncology/Surgery |  |  |  |  |  |  |  |  |  |  |
Net sales by Product Category |  |  |  |  |  |  |  |  |  |  |
Net sales |  |  |  |  |  |  |  |  | $ 49,191 | $ 44,560 | $ 48,895

X
- Definition Net Sales by Product Category [Abstract] + References No definition available. + Details
Name: | ango_NetSalesByProductCategoryAbstract
Namespace Prefix: | ango_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_ProductOrServiceAxis=ango_PeripheralVascularMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=ango_AccessMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=ango_OncologySurgeryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |